Cindy Lundin Mesaros
Vertrieb & Marketing bei Foresite Capital Management LLC
Ursprung des Netzwerks ersten Grades von Cindy Lundin Mesaros
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco.
49
| Private Company | Investment Managers | 49 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Cindy Lundin Mesaros
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| BLACKROCK, INC. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
Lighthouse Capital Partners, Inc.
 Lighthouse Capital Partners, Inc. Investment ManagersFinance Lighthouse Capital Partners, Inc. (Lighthouse Capital Partners) is a venture capital firm founded in 1994 by Richard Stubblefield and Gwill York. The firm headquartered in Menlo Park, California. | Investment Managers | Comptroller/Controller/Auditor Director of Finance/CFO | |
| 10X GENOMICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Analyst | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree | |
Carnegie Corp. of New York
 Carnegie Corp. of New York Investment Trusts/Mutual FundsMiscellaneous Carnegie Corp. of New York (Carnegie) is a philanthropic grantmaking foundation headquartered in New York City. The foundation was founded in 1911 by Andrew Carnegie. Carnegie promotes the advancement and diffusion of knowledge and understanding for the benefit of the people of the United States. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree | |
| Wesleyan University | College/University | Undergraduate Degree | |
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Denver | College/University | Undergraduate Degree Graduate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Barnard College | College/University | Undergraduate Degree | |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Investment Banks/Brokers | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of California | College/University | Undergraduate Degree Undergraduate Degree | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leeds School of Business | College/University | Undergraduate Degree | |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Verily Life Sciences LLC provides healthcare solutions for global markets. The firm specializes in healthcare, hardware, software, clinical studies, scientific research, disease management platforms, sensors, population health management and precision medicine. It develops tools to collect and organize health data. The company is headquartered in South San Francisco, CA. | Packaged Software | Founder | |
GRAIL LLC
 GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Section 32 LLC
 Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Investment Managers | Consultant / Advisor Public Communications Contact | |
| Td Bank / Union New Jersey / | Corporate Officer/Principal | ||
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Foresite Labs LLC | Founder Chief Operating Officer Chief Executive Officer Private Equity Investor Private Equity Investor | ||
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| QUANTUM-SI INCORPORATED | Packaged Software | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pleno, Inc.
 Pleno, Inc. Internet Software/ServicesTechnology Services Pleno, Inc. is a company that specializes in multi-omic instrument platform technology for clinical testing and biomedical research. The company is based in San Diego, CA and was founded by Pieter van Rooyen, who has been the CEO since incorporation. The company's proprietary hypercoding™ technology uses signal processing techniques to provide targeted biological information with exceptional scale, precision, and performance. | Internet Software/Services | Director/Board Member | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 49 |
| Schweiz | 2 |
Sektoral
| Consumer Services | 18 |
| Health Technology | 15 |
| Finance | 11 |
| Technology Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 95 |
| Corporate Officer/Principal | 56 |
| Private Equity Investor | 34 |
| Undergraduate Degree | 32 |
| Founder | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Brett Zbar | 23 |
| Robert Gunderson | 17 |
| Mathai Mammen | 16 |
| Vikram Bajaj | 14 |
| Matthew Buten | 13 |
| Christine Aylward | 11 |
| Dennis Ryan | 11 |
| David Weinreich | 9 |
| Matthew Dyer | 9 |
| Elizabeth Canis | 8 |
| Fred Fiedorek | 8 |
| Dorothy J. Margolskee | 7 |
| Michael Rome | 6 |
| Mike Ulyatt | 6 |
- Börse
- Insiders
- Cindy Lundin Mesaros
- Unternehmensverbindungen
